Calton & Associates’s Carter's CRI Stock Holding History

Calton & Associates’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-524	Closed	-$63K	–	515
2017 Q4	$63K	Buy	+524	New	+$54.3K	0.02%	615

Other funds holding CRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Calton & Associates's CRI Position: Q1 2018 in Review

Calton & Associates sold out of Carter's (CRI) in Q1 2018, closing a stake of 524 shares — an estimated $63K sold.

Calton & Associates first reported a position in CRI in Q4 2017 and held it in 1 quarter. The position peaked at $63K in Q4 2017. 384 funds tracked by Wall St. Rank hold CRI as of Q1 2018.

Calton & Associates reported no remaining Carter's position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 524 Carter's shares in Q1 2018, an estimated $63K.
Calton & Associates first reported a position in Carter's in Q4 2017 and held it in 1 quarter.
Calton & Associates's Carter's position peaked at $63K in Q4 2017.
384 funds tracked by Wall St. Rank held Carter's as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.